APIXABAN FORMULATIONS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15086447

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compositions comprising crystalline apixaban particles having a D90 equal to or less than 89 μm, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to for the treatment and/or prophylaxis of thromboembolic disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PFIZER INC66 HUDSON BOULEVARD EAST LEGAL PATENT DEPT CHIEF IP COUNSEL NEW YORK NY 10001-2192
BRISTOL-MYERS SQUIBB COMPANYROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Frost, Charles Yardley, US 6 35
Jia, Jingpin Belle Mead, US 5 8
Patel, Jatin West Windsor, US 39 350
Vemavarapu, Chandra Hillsborough, US 7 37

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation